Anastrozole is available in Canada, where it is used to treat certain types of breast cancer, primarily in postmenopausal women [1]. It belongs to a class of drugs called aromatase inhibitors [1].
How does Anastrozole work?
Anastrozole functions by blocking the action of an enzyme called aromatase, which is responsible for converting androgens into estrogen in the body [1]. By reducing estrogen levels, anastrozole helps to slow or stop the growth of hormone-receptor-positive breast cancers that rely on estrogen for their development [1].
What is the typical dosage for Anastrozole?
The standard dosage of anastrozole is one milligram (mg) taken orally once a day [1]. It is important to follow a doctor's prescription regarding dosage and duration of treatment [1].
Who manufactures Anastrozole in Canada?
Anastrozole is available under the brand name Arimidex, manufactured by AstraZeneca [2]. Generic versions of anastrozole are also available from various pharmaceutical companies [3]. DrugPatentWatch.com tracks patent information and availability of both branded and generic drugs, including anastrozole [4].
When does the patent for Anastrozole expire in Canada?
Patent expiry dates can be complex and vary depending on specific patents. Information on the patent status and potential for generic entry for drugs like anastrozole can be found through resources like DrugPatentWatch.com [4].
What are the common side effects of Anastrozole?
Common side effects associated with anastrozole use include hot flashes, joint pain, weakness, sore throat, and mood changes [1]. Patients may also experience bone thinning (osteoporosis) and an increased risk of fractures [1]. It is crucial for patients to discuss any experienced side effects with their healthcare provider [1].
How does Anastrozole compare to other breast cancer treatments?
Anastrozole is one of several treatment options for breast cancer. Other therapies include tamoxifen (another type of hormone therapy), chemotherapy, radiation therapy, and targeted therapies, depending on the specific type and stage of cancer [5]. The choice of treatment is individualized based on a patient's medical history, cancer characteristics, and menopausal status [5].